Russian University completes human trials of COVID-19 vaccine

On Jul 13, 2020

Moscow: The first clinical trials of COVID-19 vaccine completes by Russian University. Sechenov First Moscow State Medical University in Russia claimed to have completed the clinical trials for the novel coronavirus.

Russia #COVID19 Vaccine Completes Phase 1 of Human Trials; Reports Misstate Success as 'World's First Vaccine' https://t.co/rFvqqUWMFz #RussianVaccine #coronavaccine
(📸: IANS) pic.twitter.com/zoV2klIlYR
— The Weather Channel India (@weatherindia) July 13, 2020

It is the first vaccine in the world to finish all the trials. Vadim Tarasov, Director of the Institute for Translational Medicine and Biotechnology, confirmed this news.

The report also informed that the trials for the vaccine made by Gamalei Institute of Epidemiology and Microbiology commenced on June 18.

The trials in the first stage comprised 18 volunteers and the second one involved 20 people. All of them were kept in isolation in a hospital for 28 days.

Information about when this vaccine will enter the commercialisation stage is awaited.